Fig. 2
From: Safety and efficacy of G2-S16 dendrimer as microbicide in healthy human vaginal tissue explants
G2-S16 dendrimer inhibition of HIV-1 infection. ETP of ectocervix explants were infected with HIV-1 THRO T/F isolate or treated with G2-S16 dendrimer 3 mM and infected. Tissue viability measured by MTT assay and HIV-1 inhibition titrated on TZM.bl reporter cell line after 2 or 5 DPI were represented. Bars represent the mean of 5 different ectocervix tissue explants made by duplicate (4 ETP/condition) ± SD. NT non-treated, DPI days post-infection